Conmed (CNMD) Tops Q3 EPS by 3c; offers guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $32.54 --0%
EPS Growth %: -3.5%
Financial Fact:
Provision for income taxes: 2.65M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -3.5%
Financial Fact:
Provision for income taxes: 2.65M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q3 EPS of $1.08, $0.03 better than the analyst estimate of $1.05. Revenue for the quarter came in at $337.9 million versus the consensus estimate of $334.71 million.
GUIDANCE:
Conmed sees FY2025 EPS of $4.48-$4.53, versus the consensus of $4.47. Conmed sees FY2025 revenue of $1.365-1.372 billion, versus the consensus of $1.367 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Italy’s Meloni said to consider April election amid falling support
- Contango Silver & Gold starts drilling at Lucky Shot, updates on key projects
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
